"Vascular Remodeling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The active alterations of vascular wall structures, often leading to elevated VASCULAR RESISTANCE. It is associated with AGING; ATHEROSCLEROSIS; DIABETES MELLITUS; HYPERTENSION; PREGNANCY; PULMONARY HYPERTENSION; and STROKE, but is also a normal part of EMBRYOGENESIS.
| Descriptor ID |
D066253
|
| MeSH Number(s) |
C23.300.977 C23.550.918 G09.330.930
|
| Concept/Terms |
Vascular Remodeling- Vascular Remodeling
- Remodeling, Vascular
- Remodelings, Vascular
- Vascular Remodelings
Pulmonary Arterial Remodeling- Pulmonary Arterial Remodeling
- Arterial Remodeling, Pulmonary
- Arterial Remodelings, Pulmonary
- Pulmonary Arterial Remodelings
- Remodeling, Pulmonary Arterial
- Remodelings, Pulmonary Arterial
|
Below are MeSH descriptors whose meaning is more general than "Vascular Remodeling".
Below are MeSH descriptors whose meaning is more specific than "Vascular Remodeling".
This graph shows the total number of publications written about "Vascular Remodeling" by people in this website by year, and whether "Vascular Remodeling" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 3 | 3 |
| 2020 | 3 | 5 | 8 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 3 | 3 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vascular Remodeling" by people in Profiles.
-
Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm. Arterioscler Thromb Vasc Biol. 2025 07; 45(7):1044-1063.
-
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. 2024 Jul 23; 150(4):302-316.
-
PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia. Sci Rep. 2021 01 15; 11(1):1518.
-
Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis. Br J Pharmacol. 2017 Oct; 174(19):3284-3301.
-
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2016 Apr; 54(4):574-83.